The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI's Chief Executive Officer, will participate in the "Defining the Next Chapter in Value-Based Care" panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.
加利福尼亚州塞里托斯，2024年5月7日（GLOBE NEWSWIRE）——美国最大的基于价值的肿瘤学诊所之一肿瘤学研究所公司（纳斯达克股票代码：TOI）今天宣布，TOI首席执行官丹尼尔·维尔尼奇博士将参加美国东部时间5月上午8点30分在蒙特西托举行的Leerink医疗转型峰会上的 “定义基于价值的护理的下一个篇章” 小组讨论 2024 年 16 日。
About The Oncology Institute, Inc.
关于肿瘤研究所有限公司
Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit .
肿瘤学研究所及其附属公司（纳斯达克股票代码：TOI）成立于2007年，通过在社区环境中提供高度专业化、基于价值的癌症护理来推动肿瘤学发展。TOI为超过180万名患者提供尖端的循证癌症护理，包括临床试验、输血和传统上与最先进的医疗服务组织相关的其他护理提供模式。TOI 拥有 110 多名临床医生和 70 多个诊所，而且还在不断增长，正在使肿瘤学向更好的方向发展。欲了解更多信息，请访问。
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
投资者
索尔伯里战略传播
investors@theoncologyinstitute.com